NeuroPace Inc
NPCE· Nasdaq
Filed May 12, 2022 · 10-Q · 42 days after period end · 0001528287-22-000012
| Metric | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|
| Revenue | $11.37M | $11.22M | $9.98M |
| Net Income | -$11.46M | -$8.81M | -$6.74M |
| EPS Diluted | -$0.47 | -$32.73 | -$33.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NeuroPace Inc · CIK 1528287 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 12, 2022 · 42 d after period end